Cargando…
How much can we learn about missing data?: an exploration of a clinical trial in psychiatry
When a randomized controlled trial has missing outcome data, any analysis is based on untestable assumptions, e.g. that the data are missing at random, or less commonly on other assumptions about the missing data mechanism. Given such assumptions, there is an extensive literature on suitable methods...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916212/ https://www.ncbi.nlm.nih.gov/pubmed/20711246 http://dx.doi.org/10.1111/j.1467-985X.2009.00627.x |
_version_ | 1782185005308444672 |
---|---|
author | Jackson, Dan White, Ian R Leese, Morven |
author_facet | Jackson, Dan White, Ian R Leese, Morven |
author_sort | Jackson, Dan |
collection | PubMed |
description | When a randomized controlled trial has missing outcome data, any analysis is based on untestable assumptions, e.g. that the data are missing at random, or less commonly on other assumptions about the missing data mechanism. Given such assumptions, there is an extensive literature on suitable methods of analysis. However, little is known about what assumptions are appropriate. We use two sources of ancillary data to explore the missing data mechanism in a trial of adherence therapy in patients with schizophrenia: carer-reported (proxy) outcomes and the number of contact attempts. This requires additional assumptions to be made whose plausibility we discuss. Proxy outcomes are found to be unhelpful in this trial because they are insufficiently associated with patient outcome and because the ancillary assumptions are implausible. The number of attempts required to achieve a follow-up interview is helpful and suggests that these data are unlikely to depart far from being missing at random. We also perform sensitivity analyses to departures from missingness at random, based on the investigators’ prior beliefs elicited at the start of the trial. Wider use of techniques such as these will help to inform the choice of suitable assumptions for the analysis of randomized controlled trials. |
format | Text |
id | pubmed-2916212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-29162122010-08-14 How much can we learn about missing data?: an exploration of a clinical trial in psychiatry Jackson, Dan White, Ian R Leese, Morven J R Stat Soc Ser A Stat Soc Original Articles When a randomized controlled trial has missing outcome data, any analysis is based on untestable assumptions, e.g. that the data are missing at random, or less commonly on other assumptions about the missing data mechanism. Given such assumptions, there is an extensive literature on suitable methods of analysis. However, little is known about what assumptions are appropriate. We use two sources of ancillary data to explore the missing data mechanism in a trial of adherence therapy in patients with schizophrenia: carer-reported (proxy) outcomes and the number of contact attempts. This requires additional assumptions to be made whose plausibility we discuss. Proxy outcomes are found to be unhelpful in this trial because they are insufficiently associated with patient outcome and because the ancillary assumptions are implausible. The number of attempts required to achieve a follow-up interview is helpful and suggests that these data are unlikely to depart far from being missing at random. We also perform sensitivity analyses to departures from missingness at random, based on the investigators’ prior beliefs elicited at the start of the trial. Wider use of techniques such as these will help to inform the choice of suitable assumptions for the analysis of randomized controlled trials. Blackwell Publishing Ltd 2010-07 /pmc/articles/PMC2916212/ /pubmed/20711246 http://dx.doi.org/10.1111/j.1467-985X.2009.00627.x Text en © 2010 The Royal Statistical Society and Blackwell Publishing Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Original Articles Jackson, Dan White, Ian R Leese, Morven How much can we learn about missing data?: an exploration of a clinical trial in psychiatry |
title | How much can we learn about missing data?: an exploration of a clinical trial in psychiatry |
title_full | How much can we learn about missing data?: an exploration of a clinical trial in psychiatry |
title_fullStr | How much can we learn about missing data?: an exploration of a clinical trial in psychiatry |
title_full_unstemmed | How much can we learn about missing data?: an exploration of a clinical trial in psychiatry |
title_short | How much can we learn about missing data?: an exploration of a clinical trial in psychiatry |
title_sort | how much can we learn about missing data?: an exploration of a clinical trial in psychiatry |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916212/ https://www.ncbi.nlm.nih.gov/pubmed/20711246 http://dx.doi.org/10.1111/j.1467-985X.2009.00627.x |
work_keys_str_mv | AT jacksondan howmuchcanwelearnaboutmissingdataanexplorationofaclinicaltrialinpsychiatry AT whiteianr howmuchcanwelearnaboutmissingdataanexplorationofaclinicaltrialinpsychiatry AT leesemorven howmuchcanwelearnaboutmissingdataanexplorationofaclinicaltrialinpsychiatry |